SEC Form 4 · accession 0001162194-19-000007
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel D Colella
Director
Period of report
Feb 12, 2019
Accepted (ET)
Feb 14, 2019 · 9:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 12, 2019 | A | 9,748 | $0.00 | A | 95,771 | D | |
| Common StockF2 | holding | — | — | — | 5,561 | I | Colella Family Partners, L.P | |
| Common Stock | holding | — | — | — | 53,395 | I | Colella Family Exempt Marital Deduction Trust dated 9/21/1992 | |
| Common Stock | holding | — | — | — | 3,326 | I | Colella Family Non-Exempt Marital Deduction Trust dated 9/21/1992 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. Subject to the Reporting Person's continued service with the Issuer through each applicable vesting date, twenty-five percent (25%) of the shares underlying the Restricted Stock Units shall vest quarterly on the last day of each quarter during 2019.
- F2The shares are held by Colella Family Partners, L.P. ("Colella Partners"). The shares were received in in-kind distributions by Versant Ventures I, LLC, which is the general partner of each of Versant Venture Capital I, L.P., Versant Side Fund I, L.P., Versant Affiliates Fund I-A, L.P. and Versant Affiliates Fund I-B, L.P. (collectively, the "Versant Funds"), on November 4, 2013. The Reporting Person is the General Partner of Colella Partners. The Reporting Person disclaims beneficial ownership of such shares held by Colella Partners, except to the extent of his proportionate pecuniary interest therein, if any.